galantax xl 8 milligram prolonged release capsules
clonmel healthcare ltd - galantamine hydrobromide - prolonged release capsules - 8 milligram
galantax xl 24 milligram prolonged release capsules
clonmel healthcare ltd - galantamine hydrobromide - prolonged release capsules - 24 milligram
mithegan xl 8 milligram prolonged release capsules
pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 8 milligram
mithegan xl 16 milligram prolonged release capsules
pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 16 milligram
mithegan xl 24 milligram prolonged release capsules
pharmathen s.a. - galantamine hydrobromide - prolonged release capsules - 24 milligram
reminyl xl 8mg prolonged-release capsules
ltt pharma limited - galantamine hydrobromide - prolonged-release capsule - 8 milligram(s) - anticholinesterases; galantamine
gamine xr galantamine (as hydrobromide) 24mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 30.756 mg (equivalent: galantamine, qty 24 mg) - capsule, modified release - excipient ingredients: indigo carmine; iron oxide red; erythrosine; gelatin; hypromellose; magnesium stearate; titanium dioxide; iron oxide yellow; microcrystalline cellulose; ethylcellulose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
gamine xr galantamine (as hydrobromide) 16mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 20.504 mg (equivalent: galantamine, qty 16 mg) - capsule, modified release - excipient ingredients: gelatin; ethylcellulose; titanium dioxide; microcrystalline cellulose; iron oxide red; magnesium stearate; hypromellose - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
gamine xr galantamine (as hydrobromide) 8mg modified release capsules blister pack
arrotex pharmaceuticals pty ltd - galantamine hydrobromide, quantity: 10.252 mg (equivalent: galantamine, qty 8 mg) - capsule, modified release - excipient ingredients: hypromellose; gelatin; magnesium stearate; microcrystalline cellulose; ethylcellulose; titanium dioxide - galantamine is indicated for the treatment of mild to moderately severe dementia of the alzheimer type
galantamine retard mylan 16 mg hard caps. prol.-rel.
viatris gx bv-srl - galantamine hydrobromide 20,512 mg - eq. galantamine 16 mg - prolonged-release capsule, hard - 16 mg - galantamine hydrobromide 20.512 mg - galantamine